BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tripathi K, Goel A, Singhai A, Garg M. Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder. World J Clin Oncol 2020; 11(8): 614-628 [PMID: 32879848 DOI: 10.5306/wjco.v11.i8.614]
URL: https://www.wjgnet.com/2218-4333/full/v11/i8/614.htm
Number Citing Articles
Ti-Chun Chan, Yow-Ling Shiue, Chien-Feng Li. The biological impacts of CEBPD on urothelial carcinoma development and progressionFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1123776
Pratishtha Gupta, Niraj Kumar, Minal Garg. Emerging roles of autophagy in the development and treatment of urothelial carcinoma of the bladderExpert Opinion on Therapeutic Targets 2021; 25(9): 787 doi: 10.1080/14728222.2021.1992384
Richard L. Pullen. Bladder cancerNursing 2024; 54(4): 27 doi: 10.1097/01.NURSE.0001007608.96581.fa
Jidong Zhao, Xiangmei Zhang, Ming He, Xin Chen, Xing Cui, Tian Qin, Xueliang Niu, Liyan Zhao. Poor Prognosis of Pulmonary Adenosquamous Carcinoma with NRAS and HRAS Double MutationOncoTargets and Therapy 2021; : 1113 doi: 10.2147/OTT.S295813
Kiran Tripathi, Apul Goel, Atin Singhai, Minal Garg. Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladderMolecular Biology Reports 2021; 48(3): 2183 doi: 10.1007/s11033-021-06227-x